United Therapeutics Corp
UTHR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001082554
In the last 90 days, United Therapeutics Corp insiders filed 0 open-market purchases and 72 sales; 889 institutions reported holding it in 13F filings for Q2 2026, worth $22.6B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 9, 2026
- $24.8B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $339.1M in total
- 72
- 13F holdersQ2 2026, +38 vs. previous quarter
- 889
- 13F valueReported value at the end of Q2 2026
- $22.6B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $3.18B
- +10.6% year over year
- Net income, FY2025
- $1.33B
- +11.7% year over year
- Free cash flow, FY2025
- $1.04B
- −3.7% year over year
- Revenue, Q3 FY2026
- $832.5M
- +4.1% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 2.46M
- Shares sold short
- Change
- −1.14M
- −31.7% vs. previous
- Days to cover
- 2.57
- At average daily volume
Superinvestors holding UTHR, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding UTHR at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by United Therapeutics Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 9, 2026 (view filing)5:41 PM ET | Nov 6 | 3 days | Rothblatt Martine AChairperson & CEO | SSale | −9.50K | $564.51 | −$5.36M | −2.8%324.4K after | 9 lots10b5-1 |
| Nov 6, 2026 (view filing)4:57 PM ET | Nov 5 | 1 day | Rothblatt Martine AChairperson & CEO | SSale | −1.96K | $597.76 | −$1.17M | −0.6%324.4K after | 9 lots10b5-1 |
| Nov 6, 2026 (view filing)4:54 PM ET | Nov 5 | 1 day | Rothblatt Martine AChairperson & CEO | SSale | −7.54K | $573.89 | −$4.33M | −2.3%326.4K after | 24 lots10b5-1 |
| Nov 5, 2026 (view filing)5:21 PM ET | Nov 4 | 1 day | Rothblatt Martine AChairperson & CEO | SSale | −1.72K | $611.06 | −$1.05M | −0.5%324.4K after | 4 lots10b5-1 |
| Nov 5, 2026 (view filing)5:21 PM ET | Nov 4 | 1 day | Rothblatt Martine AChairperson & CEO | SSale | −7.78K | $599.64 | −$4.66M | −2.3%326.2K after | 24 lots10b5-1 |
| Nov 5, 2026 (view filing)5:15 PM ET | Nov 5 | Same day | Mahon Paul AEVP & GENERAL COUNSEL | SSale | −8.30K | $598.67 | −$4.97M | −15.5%45.2K after | 9 lots10b5-1 |
| Nov 4, 2026 (view filing)4:38 PM ET | Nov 3 | 1 day | Rothblatt Martine AChairperson & CEO | SSale | −9.50K | $601.92 | −$5.72M | −2.8%324.4K after | 8 lots10b5-1 |
| Nov 3, 2026 (view filing)4:30 PM ET | Nov 2 | 1 day | Rothblatt Martine AChairperson & CEO | SSale | −9.50K | $596.22 | −$5.66M | −2.8%324.4K after | 7 lots10b5-1 |
| Nov 2, 2026 (view filing)4:34 PM ET | Oct 30 | 3 days | Rothblatt Martine AChairperson & CEO | SSale | −9.50K | $600.09 | −$5.70M | −2.8%324.4K after | 13 lots10b5-1 |
| Oct 30, 2026 (view filing)4:30 PM ET | Oct 29 | 1 day | Rothblatt Martine AChairperson & CEO | SSale | −9.50K | $594.78 | −$5.65M | −2.8%324.4K after | 9 lots10b5-1 |
Top 10 13F holders, Q2 2026
See all 889 holdersThe largest institutional positions in United Therapeutics Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5,294,529 | $2.87B | 0.04% | −105,120−1.9% | Reduced |
| Avoro Capital Advisors LLC | 2,777,777 | $1.51B | 13.52% | +147,777+5.6% | Added |
| Vanguard Portfolio Management LLC | 1,919,429 | $1.04B | 0.05% | −84,313−4.2% | Reduced |
| Vanguard Capital Management LLC | 1,918,256 | $1.04B | 0.02% | −39,283−2.0% | Reduced |
| State Street Corp | 1,898,064 | $1.03B | 0.03% | +54,101+2.9% | Added |
| Renaissance Technologies LLC | 1,708,739 | $925.8M | 1.27% | −78,280−4.4% | Reduced |
| Wellington Management Group LLP | 1,379,025 | $747.2M | 0.13% | −885,222−39.1% | Reduced |
| Geode Capital Management, LLC | 996,598 | $538.9M | 0.03% | −236,431−19.2% | Reduced |
| Jupiter Topco LLC | 831,129 | $450.1M | 0.18% | +831,129 | New |
| Norges Bank | 694,753 | $376.4M | 0.04% | +694,753 | New |
Holders of 5% or more of UTHR
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of United Therapeutics Corp.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 13G | 5.19%2.28M shares | New | Apr 30, 20261 filing | Apr 30, 2026 | SEC |
Politician trades
All politician trades in UTHR2 members of Congress reported 5 trades in United Therapeutics Corp since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Nov 21, 2025 |  Lisa C. McClain House · MI | Buy | $1K-$15K |
| Nov 21, 2025 | Lisa C. McClain House · MI | Sell | $1K-$15K |
| Nov 21, 2025 | Lisa C. McClain House · MI | Sell | $1K-$15K |
| Aug 13, 2025 | Lisa C. McClain House · MI | Buy | $1K-$15K |
| Apr 27, 2020 |  Donna E. Shalala House · FL | Sell | $1K-$15K |
House · MI · Nov 21, 2025
Buy$1K-$15K
House · MI · Nov 21, 2025
Sell$1K-$15K
House · MI · Nov 21, 2025
Sell$1K-$15K
House · MI · Aug 13, 2025
Buy$1K-$15K
House · FL · Apr 27, 2020
Sell$1K-$15K